EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.26 | buspirone | 25% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | chlorpromazine | 55% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | citalopram | 27% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | clozapine | 40% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | desipramine | 20% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | duloxetine | 21% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | escitalopram | 39% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | flupenthixol | 56% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | imipramine | 29% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | ketanserin | mixed type inhibitor, 49% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | lamotrigine | 22% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | levomepromazine | 32% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | mianserin | 15% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | additional information | not inhibited by carbamazepine, bupropion, diazepam, fluoxetine, haloperidol, lithium, maprotiline, mirtazapine, moclobemide, pargyline, pinoline, scopolamine, selegiline, sulpiride, venlafaxine, and valpraote at 0.01 mM concentration | Rattus norvegicus | |
3.4.21.26 | pimozide | 11% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | prazosin | 91% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | prochlorperazine | 77% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | promazine | 64% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | reboxetine | 13% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | reserpine | 18% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | risperidone | 56% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | ritanserin | 33% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | thioridazine | non-competitive inhibitor, 91% inhibition at 0.01 mM | Rattus norvegicus | |
3.4.21.26 | Valproate | competitive inhibitor, 56% inhibition at 0.5 mM | Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.26 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.21.26 | brain | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.26 | N-succinyl-glycyl-prolyl-7-amido-4-methylcoumarin + H2O | - |
Rattus norvegicus | N-succinyl-glycyl-prolyl + 7-amino-4-methylcoumarin | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.21.26 | POP | - |
Rattus norvegicus |